Press Release Archive

09.12.2007

Canadian Court Finds Infringement of Lipitor Crystal Form Patent

09.05.2007

Pfizer Oncology Initiates Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib in Advanced Non-Small Cell Lung Cancer

09.05.2007

Pfizer Launches Five Year, Three Country Initiative for Malaria Treatment and Education - Mobilize Against Malaria

09.05.2007

Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference

09.04.2007

Patients Who Switched from Established Lipitor Therapy to Simvastatin Experienced a Significant 30 Percent Increase in Relative Risk of Cardiovascular Events or Death, New Observational Study Shows

08.26.2007

Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program

08.21.2007

Pfizer Names Frank A. D'Amelio Chief Financial Officer

08.06.2007

Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA

08.02.2007

Breast Cancer Guidelines Confirm Central Role of 'Switch Strategy'; Recommendations of St Gallen Panel Support Exemestane Indication

07.30.2007

First Medication to Prevent and Treat Vomiting in Dogs Now Available by Prescription

07.24.2007

Spanish Court Rules in Pfizer's Favor, Upholds Lipitor Patent

07.24.2007

Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show